Clinical Trial: Pharmacokinetic and Early Efficacy of OPT101 in Patients With Type 1 Diabetes Mellitus

U.S., May 10 -- ClinicalTrials.gov registry received information related to the study (NCT06964087) titled 'Pharmacokinetic and Early Efficacy of OPT101 in Patients With Type 1 Diabetes Mellitus' on April 14.

Brief Summary: This study will examine the safety of three times weekly SC injections of OPT101 at each of three dose levels over two weeks as well as one year of treatment with SC OPT101 or placebo to match at a single dose level.

Study Start Date: May 27

Study Type: INTERVENTIONAL

Condition: Type I Diabetes

Intervention: DRUG: OPT101

Subcutaneous injection.

OTHER: OPT101 Placebo to Match (PTM)

5% Dextrose (w/v)

Recruitment Status: NOT_YET_RECRUITING

Sponsor: Op-T LLC

Disclaimer: Curated by HT Syndication....